Knowledge Center

White Paper / May 08, 2026

Integrated Nasal Powder Development Platform

Authors:
  • Claudia Costa
  • Dina Morais
Source:
Hovione White Paper

Why are nasal powders finally having their moment?

Nasal powder drug products are moving from niche to necessity. The intranasal route uniquely combines patient convenience, fast onset, and access to therapeutic spaces that are otherwise diffcult to reach, particularly the brain via olfactory and trigeminal pathways. 

Read the full white paper

 

 

Related links

Read the full white paper here

Also in the Knowledge Center

Related Content

Cryogenics

Hovione has experience in carrying out reactions at low temperatures.

Page
Read more

Drug Substance Sustainability

At Hovione, sustainability is embedded into every stage. Guided by sustainability-by-design and over 20 years of Green Chemistry expertise, we deliver cleaner, smarter, and more efficient solutions - helping you reduce environmental impact, meet regulatory expectations, and improve process performance.

Page
Read more

Continuous Tableting for Drug Product

Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more